Cyanine compounds

Abstract

Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.

What is claimed is: 
     
         1 . A compound of general formula IIa 
       
         
           
           
               
               
           
         
       
       or general formula IIb 
       
         
           
           
               
               
           
         
       
       wherein each of R 1 , R 2 , R 5 , and R 6  is the same or different and is independently selected from the group consisting of aliphatic, heteroaliphatic, sulfoalkyl, heteroaliphatic with terminal SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, a sulfonamide group -L-SO 2 NH—P-L-Z, and a caboxamide group -L-CONH—P-L-Z;
 each of R 7  and R 8  is the same or different and is independently selected from the group consisting of H, SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group, where the (poly)ethylene glycol group is (CH 2 CH 2 O) s , where s is an integer from 3-6 inclusive, a sulfonamide group —SO 2 NH—P-L-Z, and a caboxamide group —CONH—P-L-Z; 
 where L is selected from the group consisting of a divalent linear (—(CH 2 ) o —, o=0 to 15), crossed, or cyclic alkane group that is optionally substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and/or sulfur; 
 where Z is selected from the group consisting of H, CH 3 , alkyl, heteroalkyl, NH 2 , —COO − , —COOH, —COSH, CO—NH—NH 2 , —COF, —COCl, —COBr, —COI, —COO-Su (succinimidyl/sulfosuccinimidyl), —COO—STP (4-sulfo-2,3,5,6-tetrafluorophenyl), —COO-TFP (2,3,5,6-tetrafluorophenyl), —COO-benzotriazole, —CO-benzotriazole, —CONR′—CO—CH 2 —I, —CONR′R″, —CONR′-biomolecule, —CONR′-L-COO − , —CONR′-L-COOH, —CONR′-L-COO-Su, —CONR′-L-COO—STP, —CONR′-L-COO-TFP, —CONR′-L-CONR″ 2 , —CONR′-L-CO-biomolecule, —CONR′-L-CO—NH—NH 2 , —CONR′-L-OH, —CONR′-L-O-phosphoramidite, —CONR′-L-CHO, —CONR′-L-maleimide, and —CONR′-L-NH—CO—CH 2 —I; R′ and R″ is selected from the group consisting of H, aliphatic group, and heteroaliphatic group, and the biomolecule is a protein, antibody, nucleotide, oligonucleotide, biotin, or hapten; 
 X is selected from the group consisting of —OH, —SH, —NH 2 , —NH—NH 2 , —F, —Cl, —Br, I, —NHS (hydroxysuccinimidyl/sulfosuccinimidyl), —O-TFP (2,3,5,6-tetrafluorophenoxy), —O-STP (4-sulfo-2,3,5,6-tetrafluorophenoxy), —O-benzotriazole, -benzotriazole, —NR-L-OH, —NR-L-O-phosphoramidite, —NR-L-SH, —NR-L-NH 2 , —NR-L-NH—NH 2 , —NR-L-CO 2 H, —NR-L-CO—NHS, —NR-L-CO-STP, —NR-L-CO-TFP, —NR-L-CO-benzotriazole, —NR-L-CHO, —NR-L-maleimide, and —NR-L-NH—CO—CH 2 —I, where R is —H or an aliphatic or heteroaliphatic group; 
 Kat is a number of Na + , K + , Ca 2+ , ammonia, or other cation(s) needed to compensate the negative charge brought by the cyanine; m is an integer from 0 to 5 inclusive; o is an integer from 0 to 12 inclusive; and n is an integer from 1 to 3 inclusive; with the proviso that at least one of R 1 , R 2 , R 5 , R 6 , R 7 , and R 8  contains a PEG group. 
 
     
     
         2 . A compound selected from the group consisting of 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       wherein each of R 1 , R 2 , R 5 , and R 6  is the same or different and is independently selected from the group consisting of aliphatic, heteroaliphatic, sulfoalkyl, heteroaliphatic with terminal SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, a sulfonamide group -L-SO 2 NH—P-L-Z, and a caboxamide group -L-CONH—P-L-Z;
 each of R 7  and R 8  is the same or different and is independently selected from H, SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, a sulfonamide —SO 2 NH—P-L-Z, or a caboxamide —CONH—P-L-Z; 
 where L is selected from the group consisting of a divalent linear (—(CH 2 ) o —, o=0 to 15), crossed, or cyclic alkane group optionally substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and/or sulfur; 
 where Z is selected from the group consisting of H, CH 3 , alkyl, a heteroalkyl group, NH 2 , —COO − , —COOH, —COSH, CO—NH—NH 2 , —COF, —COCl, —COBr, —COI, —COO-Su (succinimidyl/sulfosuccinimidyl), —COO—STP (4-sulfo-2,3,5,6-tetrafluorophenyl), —COO-TFP (2,3,5,6-tetrafluorophenyl), —COO-benzotriazole, —CO-benzotriazole, —CONR′—CO—CH 2 —I, —CONR′R″, —CONR′-biomolecule, —CONR′-L-COO − , —CONR′-L-COOH, —CONR′-L-COO-Su, —CONR′-L-COO—STP, —CONR′-L-COO-TFP, —CONR′-L-CONR″ 2 , —CONR′-L-CO-biomolecule, —CONR′-L-CO—NH—NH 2 , —CONR′-L-OH, —CONR′-L-O-phosphoramidite, —CONR′-L-CHO, —CONR′-L-maleimide, and —CONR′-L-NH—CO—CH 2 —I; R′ and R″ is selected from the group consisting of H, aliphatic, and heteroaliphatic, and the biomolecule is a protein, antibody, nucleotide, oligonucleotide, biotin, or hapten; 
 X is selected from the group consisting of —OH, —SH, —NH 2 , —NH—NH 2 , —F, —Cl, —Br, I, —NHS (hydroxysuccinimidyl/sulfosuccinimidyl), —O-TFP (2,3,5,6-tetrafluorophenoxy), —O-STP (4-sulfo-2,3,5,6-tetrafluorophenoxy), —O-benzotriazole, -benzotriazole, —NR-L-OH, —NR-L-O-phosphoramidite, —NR-L-SH, —NR-L-NH 2 , —NR-L-NH—NH 2 , —NR-L-CO 2 H, —NR-L-CO—NHS, —NR-L-CO-STP, —NR-L-CO-TFP, —NR-L-CO-benzotriazole, —NR-L-CHO, —NR-L-maleimide, and —NR-L-NH—CO—CH 2 —I, where R is —H, aliphatic, or heteroaliphatic; 
 Kat is a number of Na + , K + , Ca 2+ , ammonia, or other cation(s) needed to compensate the negative charge brought by the cyanine; m is an integer from 0 to 5 inclusive; o is an integer from 0 to 12 inclusive; 
 each of R3 and R4 is the same or different and is independently —H, aliphatic, heteroaliphatic, or a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive; or R3 and R4 together form a cyclic structure where R3 and R4 are joined using a divalent structural element selected from the group consisting of —(CH 2 ) q —, —(CH 2 ) q O(CH 2 ) q′ —, —(CH 2 ) q S(CH 2 ) q′ —, —(CH 2 ) q CH═CH—, —OCH═CH— where each of q and q′ is the same or different and is a integer from 2 to 6 inclusive; and 
 Y is selected from the group consisting of hydrogen, alkyl, sulfoalkyl, fluorine, chlorine, bromine, a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, and an oxygen-containing group OR PM  where R PM  is selected from the group consisting of —H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cyclic alkyl, substituted or unsubstituted heterocyclic alkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, where the group is optionally substituted one or more times with at least one of hydroxyl, sulfo, carboxy, and/or amino; with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8  contains a PEG group. 
 
     
     
         3 . A compound selected from the group consisting of 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
       wherein each of R 1 , R 2 , R 5 , and R 6  is the same or different and is independently selected from the group consisting of aliphatic, heteroaliphatic, sulfoalkyl, heteroaliphatic with terminal SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, a sulfonamide group -L-SO 2 NH—P-L-Z, and a caboxamide group -L-CONH—P-L-Z;
 each of R 7  and R 8  is the same or different and is independently selected from H, SO 3 , a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, a sulfonamide group —SO 2 NH—P-L-Z, or a caboxamide group —CONH—P-L-Z; 
 where L is selected from the group consisting of a divalent linear (—(CH 2 ) o —, o=0 to 15), crossed, or cyclic alkane group that can be substituted by at least one atom selected from the group consisting of oxygen, substituted nitrogen, and/or sulfur; 
 where Z is selected from the group consisting of H, CH 3 , alkyl, heteroalkyl, NH 2 , —COO − , —COOH, —COSH, CO—NH—NH 2 , —COF, —COCl, —COBr, —COI, —COO-Su (succinimidyl/sulfo-succinimidyl), —COO—STP (4-sulfo-2,3,5,6-tetrafluorophenyl), —COO-TFP (2,3,5,6-tetrafluorophenyl), —COO-benzotriazole, —CO-benzotriazole, —CONR′—CO—CH 2 —I, —CONR′R″, —CONR′-biomolecule, —CONR′-L-COO − , —CONR′-L-COOH, —CONR′-L-COO-Su, —CONR′-L-COO—STP, —CONR′-L-COO-TFP, —CONR′-L-CONR″ 2 , —CONR′-L-CO-biomolecule, —CONR′-L-CO—NH—NH 2 , —CONR′-L-OH, —CONR′-L-O-phosphoramidite, —CONR′-L-CHO, —CONR′-L-maleimide, and —CONR-L-NH—CO—CH 2 —I; R′ and R″ is selected from the group consisting of —H, aliphatic group, and heteroaliphatic group, and the biomolecule is a protein, antibody, nucleotide, oligonucleotide, biotin, or hapten; 
 X is selected from the group consisting of —OH, —SH, —NH 2 , —NH—NH 2 , —F, —Cl, —Br, I, —NHS (hydroxysuccinimidyl/sulfosuccinimidyl), —O-TFP (2,3,5,6-tetrafluorophenoxy), —O-STP (4-sulfo-2,3,5,6-tetrafluorophenoxy), —O-benzotriazole, -benzotriazole, —NR-L-OH, —NR-L-O-phosphoramidite, —NR-L-SH, —NR-L-NH 2 , —NR-L-NH—NH 2 , —NR-L-CO 2 H, —NR-L-CO—NHS, —NR-L-CO-STP, —NR-L-CO-TFP, —NR-L-CO-benzotriazole, —NR-L-CHO, —NR-L-maleimide, and —NR-L-NH—CO—CH 2 —I, where R is —H, aliphatic, or heteroaliphatic; 
 Kat is a number of Na + , K + , Ca 2+ , ammonia, or other cation(s) needed to compensate the negative charge brought by the cyanine; m is an integer from 0 to 5 inclusive; p is an integer from 1 to 6 inclusive; 
 each of R3 and R4 is the same or different and is independently hydrogen, an aliphatic group, a heteroaliphatic group, or a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive; or R3 and R4 together form a cyclic structure where R3 and R4 are joined using a divalent structural element selected from the group consisting of —(CH 2 ) q —, —(CH 2 ) q O(CH 2 ) q′ —, —(CH 2 ) q S(CH 2 ) q′ —, —(CH 2 ) q CH═CH—, —OCH═CH— where each of q and q′ is the same or different and is a integer from 2 to 6 inclusive; and 
 Y is selected from the group consisting of —H, alkyl, sulfoalkyl, fluorine, chlorine, bromine, a PEG group P-L-Z where P is selected from an ethylene glycol group, a diethylene glycol group, and a (poly)ethylene glycol group where the (poly)ethylene glycol group is (CH 2 CH 2 O) s  where s is an integer from 3-6 inclusive, and an oxygen-containing group OR PM  where R PM  is selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cyclic alkyl, substituted or unsubstituted heterocyclic alkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, where the group is optionally substituted at least once with at least one of hydroxyl, sulfo, carboxy, and/or amino; with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8  contains a PEG group. 
 
     
     
         4 . The compound of  claim 3  selected from the group consisting of 
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
     
     
         5 . A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of  claim 2  in an effective concentration to at least one biomolecule under conditions sufficient for labeling the biomolecule with the compound. 
     
     
         6 . The method of  claim 5  wherein the biomolecule is selected from the group consisting of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, carbohydrate, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, inorganic carrier material, and combinations thereof. 
     
     
         7 . A method of labeling at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of  claim 3  in an effective concentration to at least one biomolecule under conditions sufficient for labeling the biomolecule with the compound. 
     
     
         8 . The method of  claim 7  wherein the biomolecule is selected from the group consisting of a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, carbohydrate, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, inorganic carrier material, and combinations thereof. 
     
     
         9 . The method of  claim 7  wherein the compound is V19-03005. 
     
     
         10 . A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of  claim 2  in an effective concentration to at least one biomolecule under conditions sufficient for binding the compound to the biomolecule, and detecting the biomolecule-bound compound. 
     
     
         11 . The method of  claim 10  wherein the biomolecule is selected from a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, carbohydrate, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, inorganic carrier material, and combinations thereof. 
     
     
         12 . The method of  claim 10  wherein the at least one biomolecule is detected in an assay selected from fluorescence microscopy, flow cytometry, in vivo imaging, immunoassay, hybridization, chromatographic assay, electrophoretic assay, microwell plate based assay, fluorescence resonance energy transfer (FRET) system, bioluminescence resonance energy transfer (BRET) system, high throughput screening, or microarray. 
     
     
         13 . The method of  claim 10  wherein the biomolecule is detected by in vivo imaging comprising providing the biomolecule-bound compound to at least one of a biological sample, tissue, or organism, and detecting the biomolecule within the at least one of a biological sample, tissue, or organism. 
     
     
         14 . A method of detecting at least one biomolecule, the method comprising providing a composition comprising at least one excipient and the compound of  claim 3  in an effective concentration to at least one biomolecule under conditions sufficient for binding the compound to the biomolecule, and detecting the biomolecule-bound compound. 
     
     
         15 . The method of  claim 14  wherein the biomolecule is selected from a protein, antibody, enzyme, nucleoside triphosphate, oligonucleotide, biotin, hapten, cofactor, lectin, antibody binding protein, carotenoid, carbohydrate, hormone, neurotransmitter, growth factors, toxin, biological cell, lipid, receptor binding drug, fluorescent proteins, organic polymer carrier material, inorganic carrier material, and combinations thereof. 
     
     
         16 . The method of  claim 14  wherein the at least one biomolecule is detected in an assay selected from fluorescence microscopy, flow cytometry, in vivo imaging, immunoassay, hybridization, chromatographic assay, electrophoretic assay, microwell plate based assay, fluorescence resonance energy transfer (FRET) system, bioluminescence resonance energy transfer (BRET) system, high throughput screening, or microarray. 
     
     
         17 . The method of  claim 14  wherein the biomolecule is detected by in vivo imaging comprising providing the biomolecule-bound compound to at least one of a biological sample, tissue, or organism, and detecting the biomolecule within the at least one of a biological sample, tissue, or organism. 
     
     
         18 . The method of  claim 14  wherein the compound is V19-03005. 
     
     
         19 . A kit for labeling and/or detecting at least one biomolecule in a sample, the kit comprising the compound of  claim 2  and at least one excipient, and instructions for use of the compound to label and/or detect a biomolecule in a sample. 
     
     
         20 . A kit for labeling and/or detecting at least one biomolecule in a sample, the kit comprising the compound of  claim 3  and at least one excipient, and instructions for use of the compound to label and/or detect a biomolecule in a sample. 
     
     
         21 . The kit of  claim 20  wherein the compound is V19-03005.